Series date: 
07/01/2022 - 7:00am CDT to 06/30/2023 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  

Frequency

Monthly

Series Director

Frank Y. Lin, MD

Series Co-Director

Sarah Scollon, MS, CGC

Target Audience and Needs

Pediatric oncologists, geneticists, molecular and anatomic pathologists, surgeons, advanced practice providers, genetic counselors, medical trainees, and other healthcare professionals require regular updates on recent advances in the field of pediatric oncology. A multidisciplinary case approach will be used to interpret clinically significant tumor and germline molecular findings (therapeutic, prognostic, and diagnostic) identified through advanced sequencing platforms. The tumor board aims to expand the knowledge of learners, evaluate advances in pediatric oncology research, implement evidence-based guidelines in clinical practice, enhance the quality of pediatric oncology care, and improve patient outcomes.

Educational Methods

Educational methods will include case presentations and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Apply the results of tumor and germline molecular testing to the diagnosis, prognosis, and treatment of pediatric cancer.
  • Demonstrate the expanding role of molecular diagnostics in formulating pediatric precision-oncology treatment strategies.
  • Use a multidisciplinary approach to interpret results of molecular diagnostics.
  • Appraise the molecular tests currently available in pediatric oncology and recognize the limitations and risks of using them.
Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 
Mackenzie Harris
mdharris@texaschildrens.org
832-824-4539
Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States
See map: Google Maps

Sessions

Session Date
Genomic Alterations Informing Treatment of Vascular Tumors 08/10/2022 - 12:00pm to 1:00pm CDT
Molecular Diagnosis of Low-Grade Brain Tumors 09/14/2022 - 12:00pm to 1:00pm CDT
Anaplastic Lymphoma Kinase Fusion 10/12/2022 - 12:00pm to 1:00pm CDT
Management of Thyroid Cancer in Children 12/14/2022 - 12:00pm to 1:00pm CST
Two Cases of Anaplastic Ganglioglioma with Distinct Molecular Drivers 01/11/2023 - 12:00pm to 1:00pm CST
Quality Assurance Presentation: Complexities of CEBPA in Pediatric Acute Myeloid Leukemia 02/08/2023 - 12:00pm to 1:00pm CST
Management Consideration for a Toddler with Li Fraumeni Syndrome and Rhabdomyosarcoma 04/12/2023 - 12:00pm to 1:00pm CDT
Theme: Results from the Molecular Characterization Initiative (MCI) 06/14/2023 - 12:00pm to 1:00pm CDT